Dr. Gus Alva Discusses an Effective Therapy for Elderly Patients with Neurodegenerative Diseases

A recent study, published in the Journal of Alzheimer’s Disease, evaluated the safety of pimavanserin compared to placebo in frail older adults and elderly patients with neuropsychiatric symptoms related to NDD, such as hallucinations and delusions.
DocWire News spoke with Dr. Gus Alva, ATP Clinical Research; Department of Psychiatry and Neuroscience, University of California at Riverside, to learn more about the significance of the findings.